Medivir: Cathepsin S Research Programme Designates Candidate Drug (CD) HUDDINGE, Sweden, March 29, 2004 (PRIMEZONE) -- Medivir and Peptimmune jointly announce today that an orally active, small molecule inhibitor of the protease enzyme Cathepsin S has been selected as a...